Semiconductors
Compare Stocks
5 / 10Stock Comparison
POET vs COHR vs LITE vs IPGP vs VIAV
Revenue, margins, valuation, and 5-year total return — side by side.
Hardware, Equipment & Parts
Communication Equipment
Semiconductors
Communication Equipment
POET vs COHR vs LITE vs IPGP vs VIAV — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | |||||
|---|---|---|---|---|---|
| Industry | Semiconductors | Hardware, Equipment & Parts | Communication Equipment | Semiconductors | Communication Equipment |
| Market Cap | $1.67B | $53.16B | $64.50B | $4.43B | $11.85B |
| Revenue (TTM) | $763K | $1.81T | $2.49B | $1.04B | $1.37B |
| Net Income (TTM) | $-51M | $191.68B | $440M | $29M | $-55M |
| Gross Margin | -17.0% | 0.1% | 37.7% | 37.6% | 55.7% |
| Operating Margin | -51.5% | 0.0% | 9.5% | 0.3% | 8.2% |
| Forward P/E | — | 61.6x | 110.1x | 78.1x | 54.7x |
| Total Debt | $7M | $3.89B | $2.61B | $0.00 | $692M |
| Cash & Equiv. | $37M | $909M | $521M | $404M | $424M |
POET vs COHR vs LITE vs IPGP vs VIAV — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| POET Technologies I… (POET) | 100 | 295.6 | +195.6% |
| Coherent, Inc. (COHR) | 100 | 705.4 | +605.4% |
| Lumentum Holdings I… (LITE) | 100 | 1232.2 | +1132.2% |
| IPG Photonics Corpo… (IPGP) | 100 | 67.2 | -32.8% |
| Viavi Solutions Inc. (VIAV) | 100 | 441.8 | +341.8% |
Price return only. Dividends and distributions are not included.
Quick Verdict: POET vs COHR vs LITE vs IPGP vs VIAV
Each card shows where this stock fits in a portfolio — not just who wins on paper.
POET lags the leaders in this set but could rank higher in a more targeted comparison.
COHR is the #2 pick in this set and the best alternative if growth exposure is your priority.
- Rev growth 23.4%, EPS growth 71.7%, 3Y rev CAGR 20.5%
- 23.4% revenue growth vs POET's -91.1%
- 0.0% yield; the other 4 pay no meaningful dividend
LITE carries the broadest edge in this set and is the clearest fit for long-term compounding.
- 36.8% 10Y total return vs COHR's 15.5%
- 17.7% margin vs POET's -66.3%
- +12.8% vs IPGP's +77.9%
- 8.5% ROA vs POET's -46.9%
IPGP is the clearest fit if your priority is income & stability and defensive.
- Dividend streak 1 yrs, beta 1.68
- Beta 1.68, current ratio 6.08x
VIAV ranks third and is worth considering specifically for sleep-well-at-night.
- Lower volatility, beta 1.65, Low D/E 88.7%, current ratio 1.50x
- Lower P/E (54.7x vs 78.1x)
- Beta 1.65 vs POET's 3.15
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 23.4% revenue growth vs POET's -91.1% | |
| Value | Lower P/E (54.7x vs 78.1x) | |
| Quality / Margins | 17.7% margin vs POET's -66.3% | |
| Stability / Safety | Beta 1.65 vs POET's 3.15 | |
| Dividends | 0.0% yield; the other 4 pay no meaningful dividend | |
| Momentum (1Y) | +12.8% vs IPGP's +77.9% | |
| Efficiency (ROA) | 8.5% ROA vs POET's -46.9% |
POET vs COHR vs LITE vs IPGP vs VIAV — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
Segment breakdown not available.
POET vs COHR vs LITE vs IPGP vs VIAV — Financial Metrics
Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
LITE leads in 3 of 6 categories
IPGP leads 1 • POET leads 0 • COHR leads 0 • VIAV leads 0 • 2 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
LITE leads this category, winning 3 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
COHR is the larger business by revenue, generating $1.81T annually — 2373737.6x POET's $762,695. LITE is the more profitable business, keeping 17.7% of every revenue dollar as net income compared to POET's -66.3%. On growth, COHR holds the edge at +1204.5% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | |||||
|---|---|---|---|---|---|
| RevenueTrailing 12 months | $762,695 | $1.81T | $2.5B | $1.0B | $1.4B |
| EBITDAEarnings before interest/tax | -$36M | $913M | $425M | $55M | $207M |
| Net IncomeAfter-tax profit | -$51M | $191.7B | $440M | $29M | -$55M |
| Free Cash FlowCash after capex | -$35M | -$537.2B | $399M | $8M | $46M |
| Gross MarginGross profit ÷ Revenue | -17.0% | +0.1% | +37.7% | +37.6% | +55.7% |
| Operating MarginEBIT ÷ Revenue | -51.5% | +0.0% | +9.5% | +0.3% | +8.2% |
| Net MarginNet income ÷ Revenue | -66.3% | +10.6% | +17.7% | +2.8% | -4.0% |
| FCF MarginFCF ÷ Revenue | -46.2% | -29.7% | +16.0% | +0.8% | +3.3% |
| Rev. Growth (YoY)Latest quarter vs prior year | +80.0% | +1204.5% | +90.1% | +16.6% | +42.8% |
| EPS Growth (YoY)Latest quarter vs prior year | +50.0% | +11190.8% | +3.3% | -54.4% | -70.2% |
Valuation Metrics
IPGP leads this category, winning 3 of 6 comparable metrics.
Valuation Metrics
At 143.1x trailing earnings, IPGP trades at a 94% valuation discount to LITE's 2441.7x P/E. On an enterprise value basis, IPGP's 50.4x EV/EBITDA is more attractive than LITE's 869.4x.
| Metric | |||||
|---|---|---|---|---|---|
| Market CapShares × price | $1.7B | $53.2B | $64.5B | $4.4B | $11.8B |
| Enterprise ValueMkt cap + debt − cash | $1.6B | $56.1B | $66.6B | $4.0B | $12.1B |
| Trailing P/EPrice ÷ TTM EPS | -11.63x | -644.73x | 2441.70x | 143.14x | 341.40x |
| Forward P/EPrice ÷ next-FY EPS est. | — | 61.57x | 110.06x | 78.05x | 54.72x |
| PEG RatioP/E ÷ EPS growth rate | — | — | — | — | 74.80x |
| EV / EBITDAEnterprise value multiple | — | 50.93x | 869.35x | 50.42x | 90.70x |
| Price / SalesMarket cap ÷ Revenue | 9999.00x | 9.15x | 39.21x | 4.42x | 10.93x |
| Price / BookPrice ÷ Book value/share | 31.85x | 6.12x | 55.41x | 2.09x | 14.81x |
| Price / FCFMarket cap ÷ FCF | — | 275.80x | — | — | 191.12x |
Profitability & Efficiency
LITE leads this category, winning 4 of 9 comparable metrics.
Profitability & Efficiency
LITE delivers a 30.7% return on equity — every $100 of shareholder capital generates $31 in annual profit, vs $-76 for POET. POET carries lower financial leverage with a 0.35x debt-to-equity ratio, signaling a more conservative balance sheet compared to LITE's 2.30x. On the Piotroski fundamental quality scale (0–9), COHR scores 7/9 vs POET's 3/9, reflecting strong financial health.
| Metric | |||||
|---|---|---|---|---|---|
| ROE (TTM)Return on equity | -76.1% | +6.9% | +30.7% | +1.4% | -6.9% |
| ROA (TTM)Return on assets | -46.9% | +4.4% | +8.5% | +1.2% | -2.3% |
| ROICReturn on invested capital | — | +3.6% | -4.3% | +0.6% | +5.5% |
| ROCEReturn on capital employed | -2.3% | +4.2% | -4.8% | +0.6% | +4.9% |
| Piotroski ScoreFundamental quality 0–9 | 3 | 7 | 7 | 6 | 5 |
| Debt / EquityFinancial leverage | 0.35x | 0.46x | 2.30x | — | 0.89x |
| Net DebtTotal debt minus cash | -$30M | $3.0B | $2.1B | -$404M | $269M |
| Cash & Equiv.Liquid assets | $37M | $909M | $521M | $404M | $424M |
| Total DebtShort + long-term debt | $7M | $3.9B | $2.6B | $0 | $692M |
| Interest CoverageEBIT ÷ Interest expense | -396.56x | 0.01x | 9.62x | — | 2.70x |
Total Returns (Dividends Reinvested)
LITE leads this category, winning 5 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in LITE five years ago would be worth $111,852 today (with dividends reinvested), compared to $5,573 for IPGP. Over the past 12 months, LITE leads with a +1275.9% total return vs IPGP's +77.9%. The 3-year compound annual growth rate (CAGR) favors LITE at 166.2% vs IPGP's -3.5% — a key indicator of consistent wealth creation.
| Metric | |||||
|---|---|---|---|---|---|
| YTD ReturnYear-to-date | +52.7% | +72.5% | +134.0% | +39.6% | +182.1% |
| 1-Year ReturnPast 12 months | +147.4% | +374.9% | +1275.9% | +77.9% | +458.5% |
| 3-Year ReturnCumulative with dividends | +147.4% | +942.8% | +1786.5% | -10.2% | +462.7% |
| 5-Year ReturnCumulative with dividends | +42.0% | +440.7% | +1018.5% | -44.3% | +216.5% |
| 10-Year ReturnCumulative with dividends | +12.8% | +1545.8% | +3680.0% | +23.6% | +718.1% |
| CAGR (3Y)Annualised 3-year return | +35.3% | +118.5% | +166.2% | -3.5% | +77.9% |
Risk & Volatility
Evenly matched — COHR and VIAV each lead in 1 of 2 comparable metrics.
Risk & Volatility
VIAV is the less volatile stock with a 1.65 beta — it tends to amplify market swings less than POET's 3.15 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. COHR currently trades 91.9% from its 52-week high vs IPGP's 67.1% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | |||||
|---|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 3.15x | 2.82x | 2.66x | 1.68x | 1.65x |
| 52-Week HighHighest price in past year | $15.50 | $364.80 | $1021.00 | $155.82 | $60.43 |
| 52-Week LowLowest price in past year | $3.87 | $67.50 | $63.98 | $58.09 | $8.87 |
| % of 52W HighCurrent price vs 52-week peak | +70.6% | +91.9% | +88.5% | +67.1% | +84.7% |
| RSI (14)Momentum oscillator 0–100 | 55.3 | 53.1 | 53.3 | 39.5 | 62.0 |
| Avg Volume (50D)Average daily shares traded | 27.4M | 6.8M | 6.5M | 504K | 6.3M |
Analyst Outlook
Evenly matched — IPGP and VIAV each lead in 1 of 1 comparable metric.
Analyst Outlook
Analyst consensus: POET as "Buy", COHR as "Buy", LITE as "Buy", IPGP as "Buy", VIAV as "Buy". Consensus price targets imply 35.2% upside for IPGP (target: $141) vs -37.0% for VIAV (target: $32).
| Metric | |||||
|---|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | Buy | Buy | Buy | Buy |
| Price TargetConsensus 12-month target | $8.00 | $324.00 | $918.67 | $141.25 | $32.25 |
| # AnalystsCovering analysts | 2 | 30 | 25 | 27 | 19 |
| Dividend YieldAnnual dividend ÷ price | — | +0.0% | — | — | — |
| Dividend StreakConsecutive years of raises | — | 0 | 0 | 1 | 1 |
| Dividend / ShareAnnual DPS | — | $0.07 | — | — | — |
| Buyback YieldShare repurchases ÷ mkt cap | 0.0% | +0.1% | +0.1% | +1.2% | +0.1% |
LITE leads in 3 of 6 categories (Income & Cash Flow, Profitability & Efficiency). IPGP leads in 1 (Valuation Metrics). 2 tied.
POET vs COHR vs LITE vs IPGP vs VIAV: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is POET or COHR or LITE or IPGP or VIAV a better buy right now?
For growth investors, Coherent, Inc.
(COHR) is the stronger pick with 23. 4% revenue growth year-over-year, versus -91. 1% for POET Technologies Inc. (POET). IPG Photonics Corporation (IPGP) offers the better valuation at 143. 1x trailing P/E (78. 1x forward), making it the more compelling value choice. Analysts rate POET Technologies Inc. (POET) a "Buy" — based on 2 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — POET or COHR or LITE or IPGP or VIAV?
On trailing P/E, IPG Photonics Corporation (IPGP) is the cheapest at 143.
1x versus Lumentum Holdings Inc. at 2441. 7x. On forward P/E, Viavi Solutions Inc. is actually cheaper at 54. 7x — notably different from the trailing picture, reflecting expected earnings growth.
03Which is the better long-term investment — POET or COHR or LITE or IPGP or VIAV?
Over the past 5 years, Lumentum Holdings Inc.
(LITE) delivered a total return of +1019%, compared to -44. 3% for IPG Photonics Corporation (IPGP). Over 10 years, the gap is even starker: LITE returned +36. 8% versus POET's +12. 8%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — POET or COHR or LITE or IPGP or VIAV?
By beta (market sensitivity over 5 years), Viavi Solutions Inc.
(VIAV) is the lower-risk stock at 1. 65β versus POET Technologies Inc. 's 3. 15β — meaning POET is approximately 90% more volatile than VIAV relative to the S&P 500. On balance sheet safety, POET Technologies Inc. (POET) carries a lower debt/equity ratio of 35% versus 2% for Lumentum Holdings Inc. — giving it more financial flexibility in a downturn.
05Which is growing faster — POET or COHR or LITE or IPGP or VIAV?
By revenue growth (latest reported year), Coherent, Inc.
(COHR) is pulling ahead at 23. 4% versus -91. 1% for POET Technologies Inc. (POET). On earnings-per-share growth, the picture is similar: Viavi Solutions Inc. grew EPS 225. 0% year-over-year, compared to -84. 3% for POET Technologies Inc.. Over a 3-year CAGR, COHR leads at 20. 5% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — POET or COHR or LITE or IPGP or VIAV?
Viavi Solutions Inc.
(VIAV) is the more profitable company, earning 3. 2% net margin versus -1368. 6% for POET Technologies Inc. — meaning it keeps 3. 2% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: COHR leads at 9. 4% versus -725. 7% for POET. At the gross margin level — before operating expenses — POET leads at 100. 0%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is POET or COHR or LITE or IPGP or VIAV more undervalued right now?
On forward earnings alone, Viavi Solutions Inc.
(VIAV) trades at 54. 7x forward P/E versus 110. 1x for Lumentum Holdings Inc. — 55. 3x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for IPGP: 35. 2% to $141. 25.
08Which pays a better dividend — POET or COHR or LITE or IPGP or VIAV?
None of the stocks in this comparison currently pay a material dividend.
All are effectively zero-yield and should be held for capital appreciation rather than income.
09Is POET or COHR or LITE or IPGP or VIAV better for a retirement portfolio?
For long-horizon retirement investors, Coherent, Inc.
(COHR) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (+1546% 10Y return). POET Technologies Inc. (POET) carries a higher beta of 3. 15 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (COHR: +1546%, POET: +12. 8%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between POET and COHR and LITE and IPGP and VIAV?
Both stocks operate in the Technology sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
In terms of investment character: POET is a small-cap quality compounder stock; COHR is a mid-cap high-growth stock; LITE is a mid-cap high-growth stock; IPGP is a small-cap quality compounder stock; VIAV is a mid-cap quality compounder stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.